Posted: 12 April 2023 The Victorian Connected Health Innovation and Commercialisation Centre (CHICC), powered by ANDHealth, was formally opened today by the Minister for Industry and Innovation, The Hon Ben Carroll MP. The Victorian Government has invested $2.4…
Posted: 12 April 2023 Alterity Therapeutics, a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced the first participant has been dosed in the United Kingdom in the Company’s Phase 2 clinical trial of…
Posted: 6 April 2023 Innovative biotech company Noxopharm Limited (ASX:NOX) announces that as part of the Board and management team’s continual operational risk and cost profile evaluation, the company has reviewed the opportunities for its growing portfolio of…
Posted: 6 April 2023 Respiratory imaging technology company 4DMedical Limited today announces a significant milestone in its commercialisation journey with the signing of a five-year contract with the University of Miami to provide XV LVAS® (X-ray Velocimetry Lung…
Posted: 4 April 2023 A world-first clinical trial platform is set to transform research into new therapies for brain cancer, delivering more targeted, personalised treatment for patients. The Brain-POP (brain perioperative) clinical trial platform enables doctors to precisely…
Posted: 4 April 2023 Firebrick Pharma is pleased to announce that its Phase 2 COVID-19 trial of Nasodine Nasal Spray has closed for recruitment. Nasal swabs collected from all subjects have been forwarded to a specialist virology laboratory…
Posted: 4 April 2023 Avecho Biotechnology Limited has today announced that it is undertaking a capital raise seeking approximately $11 million. Proceeds from the raise will be used to fund a pivotal Phase 3 clinical trial designed to test…
Posted: 4 April 2023 Optiscan Imaging Limited is pleased to announce the establishment of a new commercial operation in the United States. The expansion includes the formalisation of Optiscan Imaging, Inc. as a standalone US legal entity, along…
Last updated: 7 June 2023 Over the past year, BioMelbourne Network produced a series of seven podcasts for Global Victoria to help promote key sector strengths of the Victorian healthtech industry both here and abroad. These digital media…
Posted: 3 April 2023 Immutep Limited (ASX: IMM; NASDAQ: IMMP), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces positive final data from Part B of the TACTI-002 Phase II trial in 2nd line…
Posted: 3 April 2023 Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces it has signed an agreement to expand the INSIGHT-003…
Posted: 31 March 2023 St Vincent’s Hospital Melbourne has become the first public hospital in Australia to install the Synaptive Modus V – a robotic exoscope powered by artificial intelligence voice control that provides surgical teams with 3D…